Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 198 of 5804
-
New scan could spare throat cancer patients from unnecessary radiation side effects
Disease control Not yet recruitingOropharyngeal cancer (OPC) is the most common type of head and neck cancer. The current standard treatment for this cancer is radiotherapy (RT) of the tumour and lymph nodes of both sides of the neck, combined with concurrent chemotherapy for advanced stages. Even though a small …
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for HIV patients: cheaper chemo may work just as well for kaposi sarcoma
Disease control Not yet recruitingThis study is being done to determine if two different anti-cancer drugs, paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) have similar effects on treating Kaposi Sarcoma (KS) in people living with HIV (human immunodeficiency virus) in sub-Saharan Africa. Patients with …
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Chemo-free triplet aims to outsmart incurable lymphoma
Disease control Not yet recruitingFollicular lymphoma (FL) remains an incurable indolent B-cell lymphoma for many patients, and although rituximab-based chemoimmunotherapy can achieve high initial response rates, a substantial proportion of patients experience early progression, including POD24, which is associat…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take on brain cancer in early trial
Disease control TerminatedCentral nervous system lymphoma (CNSL) includes primary CNS lymphoma (PCNSL) and secondary CNS lymphoma (SCNSL), with diffuse large B-cell lymphoma as the predominant pathological type. Disease progression is often rapid and the relapse rate is high. Current standard treatment is…
Phase: PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Blood test may let some stomach cancer patients skip harsh chemo
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to assess if circulating tumor DNA, as assessed by Signatera tumor-informed MRD assay, can guide de-escalation of adjuvant therapy in patients with resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer. The main question it aims to answer is…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug duo aims to wipe out leukemia cells in First-Line treatment
Disease control Not yet recruitingThis phase II trial tests how well nemtabrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Nemtabrutinib is in a class of medications called kinase inhibitors. It blocks a protein called BTK, which is pre…
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for kidney transplant patients: drug targets rejection
Disease control Not yet recruitingAntibody-mediated rejection (AMR) is a major cause of worsening kidney function after a kidney transplant (kidney allograft dysfunction) and can lead to kidney failure. AMR happens when the kidney recipient's immune system makes antibodies that attack the donor kidney. Antibodies…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Heart procedure may offer lasting migraine relief, new study hopes to prove
Symptom relief Not yet recruitingMigraine is a common and often disabling condition, but its exact causes are not fully understood. Some people with migraines have a small opening in the heart wall called a patent foramen ovale (PFO). In some of these patients, closing this opening or taking a medication that in…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Ethiopian surgery infection study aims to save lives and limbs
Prevention Not yet recruitingThe study examines surgical site infections and antimicrobial resistance following life-saving surgeries like C-sections and leg fracture repairs in Ethiopia. It does not include healthy volunteers because it specifically focuses on patients who require these urgent operations du…
Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Rolling hospital room: could a mobile diagnostic unit slash nursing home hospitalisations?
Disease control Not yet recruitingThis prospective observational before-after study evaluates the impact of a Mobile Geriatric Unit (MGU) on hospitalisation rates among nursing home residents. The study includes a 12-month control phase with usual care followed by a 12-month intervention phase during which the MG…
Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a popular Weight-Loss drug help—or Harm—Those with duchenne muscular dystrophy?
Disease control Not yet recruitingDuchenne Muscular Dystrophy (DMD) is a rare, genetic disease that leads to muscle weakness, breathing difficulties, heart disease, and early death. Approximately half of individuals with DMD have elevated body mass indices (BMIs) in the overweight or obesity range. High BMI is du…
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Laughing gas tested as rapid depression treatment for dementia patients in nursing homes
Symptom relief Not yet recruitingDepression in neurocognitive disorders (Alzheimers' disease and related disoders) is a highly prevalent condition, especially in nursing homes. While it is associated with significant distress, the current conventional antidepressants have shown only modest efficacy and exposed t…
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug targets Hard-to-Treat neuroendocrine cancers
Disease control Not yet recruitingThis study will enroll patients with central lab confirmed NCAM (CD56 IHC) positive metastatic neuroendocrine neoplasms that have progressed after standard of care treatment. CTX-471 to be administered as an intravenous (IV) infusion at either 0.3 mg/kg or 0.6 mg/kg every 2 weeks…
Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
Disease control Not yet recruitingThis is a national multicenter, prospective, randomized controlled trial. The study aims to compare the 5-year overall survival (OS) between patients receiving primary tumor surgery followed by systemic therapy (surgery group) and those receiving systemic therapy alone (non-surge…
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Scientists map brain changes during Hour-Long DMT experience
Knowledge-focused Not yet recruitingThis study examines how the psychedelic substance DMT affects the human brain when administered by the intravenous (IV) route. DMT is a naturally occurring chemical in the body that is thought to help improve mood when ingested in a continuously monitored medical setting. Previou…
Phase: PHASE1 • Sponsor: Jon Dean • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Kitchen cure: culinary medicine may help reverse metabolic syndrome
Disease control Not yet recruitingMetabolic syndrome is a major public health concern associated with an increased risk of cardiovascular disease, type 2 diabetes, and premature mortality. The Mediterranean diet has consistently demonstrated beneficial effects on metabolic health and is recommended as a dietary s…
Phase: NA • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can a family program combining parenting and financial skills prevent child abuse?
Prevention Recruiting nowThe goal of this clinical trial is to learn if a family-based prevention program works to prevent child maltreatment risk and other adverse childhood experiences (ACEs) among families in Kyrgyzstan. It will also learn about the safety, feasibility, and acceptability of the progra…
Phase: NA • Sponsor: The University of Texas at Arlington • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
A PET scan and a blood test may predict which men with advanced prostate cancer will benefit from targeted therapy
Diagnosis Not yet recruitingThis multicenter center, open-label, baseline-controlled diagnostic imaging study designed to assess the use of Fluorthanatrace-Positron Emission tomography (FTT-PET) as a PARP inhibitor (PARPi) therapy predictive imaging biomarker and the use of EnhanceAR-Seq (ctDNA) in predicti…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Bedside flu shot for heart patients: a simple strategy to save lives?
Prevention Not yet recruitingThe aim of this study is to evaluate the effect of offering intrahospital influenza vaccination as an adjunct to active counseling during the index hospitalization to adult patients hospitalized for acute coronary syndrome (ACS) or congestive heart failure (CHF), compared with ac…
Phase: NA • Sponsor: Stephan Baldus • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
Knowledge-focused Not yet recruitingInflammatory lung diseases, including chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), are major causes of morbidity and mortality worldwide. Their development and progression are influenced by environmental exposures, such as cigarette smokin…
Phase: NA • Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC